Cargando…

A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

PURPOSE: Pretreatment systemic inflammatory response has been confirmed to have prognostic value in patients with inoperable non-small-cell lung cancer (NSCLC). Increasing studies show that the modified Glasgow prognostic score (mGPS), a prognostic score based on C-reactive protein (CRP) and albumin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Lizhen, Li, Xiaofen, Shen, Yanwei, Cao, Ying, Fang, Xuefeng, Chen, Jiaqi, Yuan, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982488/ https://www.ncbi.nlm.nih.gov/pubmed/27540301 http://dx.doi.org/10.2147/OTT.S107279

Ejemplares similares

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
por: Forrest, L M, et al.
Publicado: (2003)

Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients
por: Shen, Hong, et al.
Publicado: (2016)

Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
por: Forrest, L M, et al.
Publicado: (2004)

The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer
por: Scott, H R, et al.
Publicado: (2002)

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer
por: Crumley, A B C, et al.
Publicado: (2006)

Hypofractionated radiotherapy for medically inoperable stage I non‐small cell lung cancer
por: Jiang, Wei, et al.
Publicado: (2015)

Immunotherapy in inoperable stage III non-small cell lung cancer: a review
por: Jain, Natasha A, et al.
Publicado: (2019)

Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer
por: Zhu, Xiaofei, et al.
Publicado: (2017)

The prognostic value of the Naples prognostic score for patients with non-small-cell lung cancer
por: Peng, Si-Min, et al.
Publicado: (2022)

Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials
por: Zhu, Lizhen, et al.
Publicado: (2016)

Percutaneous Cryoablation for the Treatment of Medically Inoperable Stage I Non-Small Cell Lung Cancer
por: Yamauchi, Yoshikane, et al.
Publicado: (2012)

Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancer
por: Broggini, Massimo, et al.
Publicado: (2013)

Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era
por: Li, Jiakang, et al.
Publicado: (2022)

A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer
por: Forrest, L M, et al.
Publicado: (2005)

Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer
por: Collins, Brian T, et al.
Publicado: (2009)

The Modified Glasgow Prognostic Score Is an Independent Prognostic Factor in Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
por: Zhang, Peng, et al.
Publicado: (2014)

Risk‐adapted stereotactic body radiation therapy for central and ultra‐central early‐stage inoperable non‐small cell lung cancer
por: Meng, Mao‐Bin, et al.
Publicado: (2019)

Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer
por: Iino, Chikara, et al.
Publicado: (2017)

Can LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?
por: Kucukoner, Mehmet, et al.
Publicado: (2012)

Hypofractionation and Stereotactic Body Radiation Therapy in Inoperable Locally Advanced Non-small Cell Lung Cancer
por: Rico, Mikel, et al.
Publicado: (2021)

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma
por: Li, Xiaofen, et al.
Publicado: (2018)

Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer
por: Lee, Joo Ho, et al.
Publicado: (2013)

Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non-small cell lung cancer
por: Liu, Baodong, et al.
Publicado: (2015)

Short term clinical outcomes of accelerated hypofractionated radiotherapy in inoperable non-small cell lung cancer patients
por: Aye, Shoon Mya, et al.
Publicado: (2021)

Prealbumin/CRP Based Prognostic Score, a New Tool for Predicting Metastasis in Patients with Inoperable Gastric Cancer
por: Esfahani, Ali, et al.
Publicado: (2016)

Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer
por: Faria, Sergio L, et al.
Publicado: (2006)

Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer
por: Taugner, Julian, et al.
Publicado: (2020)

The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study
por: Chuang, Min-Chun, et al.
Publicado: (2021)

Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study
por: Chuang, Min-Chun, et al.
Publicado: (2018)

Inoperable Cancer
Publicado: (1901)

Efficacy of chemoradiotherapy versus radiation alone in patients with inoperable locally advanced non–small-cell lung cancer: A meta-analysis and systematic review
por: Hung, Ming-Szu, et al.
Publicado: (2019)

Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study
por: Scinto, A F, et al.
Publicado: (1999)

Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer
por: Amini, Arya, et al.
Publicado: (2012)

Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer
por: Noh, Jae Myoung, et al.
Publicado: (2015)

Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer
por: Antonio, Maite, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience
por: Hobbs, Corey J., et al.
Publicado: (2017)

Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
por: Chen, Wenrui, et al.
Publicado: (2022)

Bronchoscopic treatment of inoperable nonsmall cell lung cancer
por: Kniese, Christopher M., et al.
Publicado: (2020)

GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer
por: Zhu, Xiaoqiang, et al.
Publicado: (2018)

Predictive model of the first failure pattern in patients receiving definitive chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (LA-NSCLC)
por: Zhu, Xueru, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rhnjn8gsva5ggukggs7gkcetct